BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 35491773)

  • 1. The impact of the lung EDRN-CVC on Phase 1, 2, & 3 biomarker validation studies.
    Kammer MN; Deppen SA; Antic S; Jamshedur Rahman SM; Eisenberg R; Maldonado F; Aldrich MC; Sandler KL; Landman B; Massion PP; Grogan EL
    Cancer Biomark; 2022; 33(4):449-465. PubMed ID: 35491773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Early Detection Research Network: A National Infrastructure to Support the Discovery, Development, and Validation of Cancer Biomarkers.
    Srivastava S; Wagner PD
    Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2401-2410. PubMed ID: 32357955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Early Detection Research Network's Specimen reference sets: paving the way for rapid evaluation of potential biomarkers.
    Feng Z; Kagan J; Pepe M; Thornquist M; Ann Rinaudo J; Dahlgren J; Krueger K; Zheng Y; Patriotis C; Huang Y; Sorbara L; Thompson I; Srivastava S
    Clin Chem; 2013 Jan; 59(1):68-74. PubMed ID: 23193062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adding Rigor to Biomarker Evaluations-EDRN Experience.
    Feng Z; Pepe MS
    Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2575-2582. PubMed ID: 33172885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer biomarker discovery and development in gastrointestinal cancers: early detection research network-a collaborative approach.
    Srivastava S
    Gastrointest Cancer Res; 2007; 1(4 Suppl 2):S60-3. PubMed ID: 19360150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers and Strategy to Detect Preinvasive and Early Pancreatic Cancer: State of the Field and the Impact of the EDRN.
    Liu Y; Kaur S; Huang Y; Fahrmann JF; Rinaudo JA; Hanash SM; Batra SK; Singhi AD; Brand RE; Maitra A; Haab BB
    Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2513-2523. PubMed ID: 32532830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatics: biomarkers of early detection.
    Crichton DJ; Mattmann CA; Thornquist M; Anton K; Hughes JS
    Cancer Biomark; 2010; 9(1-6):511-30. PubMed ID: 22112493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The early detection research network: 10-year outlook.
    Srivastava S
    Clin Chem; 2013 Jan; 59(1):60-7. PubMed ID: 23160065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic, evidence-based discovery of biomarkers at the NCI.
    Prensner JR; Chinnaiyan AM; Srivastava S
    Clin Exp Metastasis; 2012 Oct; 29(7):645-52. PubMed ID: 22868876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale and design of the Hepatocellular carcinoma Early Detection Strategy study: A multi-center longitudinal initiative of the National Cancer Institute's Early Detection Research Network.
    Borges KA; Dai J; Parikh ND; Schwartz M; Nguyen MH; Roberts LR; Befeler AS; Srivastava S; Rinaudo JA; Feng Z; Marrero JA; Reddy KR
    Contemp Clin Trials; 2019 Jan; 76():49-54. PubMed ID: 30439517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction and analysis of the NCI-EDRN breast cancer reference set for circulating markers of disease.
    Marks JR; Anderson KS; Engstrom P; Godwin AK; Esserman LJ; Longton G; Iversen ES; Mathew A; Patriotis C; Pepe MS
    Cancer Epidemiol Biomarkers Prev; 2015 Feb; 24(2):435-41. PubMed ID: 25471344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalidation of salivary biomarkers for oral cancer detection.
    Elashoff D; Zhou H; Reiss J; Wang J; Xiao H; Henson B; Hu S; Arellano M; Sinha U; Le A; Messadi D; Wang M; Nabili V; Lingen M; Morris D; Randolph T; Feng Z; Akin D; Kastratovic DA; Chia D; Abemayor E; Wong DT
    Cancer Epidemiol Biomarkers Prev; 2012 Apr; 21(4):664-72. PubMed ID: 22301830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The early detection research network surface-enhanced laser desorption and ionization prostate cancer detection study: A study in biomarker validation in genitourinary oncology.
    Grizzle WE; Semmes OJ; Basler J; Izbicka E; Feng Z; Kagan J; Adam BL; Troyer D; Srivastava S; Thornquist M; Zhang Z; Thompson IM
    Urol Oncol; 2004; 22(4):337-43. PubMed ID: 15283893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New cancer biomarkers deriving from NCI early detection research.
    Verma M; Srivastava S
    Recent Results Cancer Res; 2003; 163():72-84; discussion 264-6. PubMed ID: 12903844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesothelioma Biomarkers: A Review Highlighting Contributions from the Early Detection Research Network.
    Pass HI; Alimi M; Carbone M; Yang H; Goparaju CM
    Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2524-2540. PubMed ID: 32699075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repair of the oxidative DNA damage 8-oxoguanine as a biomarker for lung cancer risk.
    Paz-Elizur T; Krupsky M; Elinger D; Schechtman E; Livneh Z
    Cancer Biomark; 2005; 1(2-3):201-5. PubMed ID: 17192041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating Molecular Biomarkers for the Early Detection of Lung Cancer: When Is a Biomarker Ready for Clinical Use? An Official American Thoracic Society Policy Statement.
    Mazzone PJ; Sears CR; Arenberg DA; Gaga M; Gould MK; Massion PP; Nair VS; Powell CA; Silvestri GA; Vachani A; Wiener RS;
    Am J Respir Crit Care Med; 2017 Oct; 196(7):e15-e29. PubMed ID: 28960111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National Lung Cancer Screening Trial American College of Radiology Imaging Network Specimen Biorepository originating from the Contemporary Screening for the Detection of Lung Cancer Trial (NLST, ACRIN 6654): design, intent, and availability of specimens for validation of lung cancer biomarkers.
    Patz EF; Caporaso NE; Dubinett SM; Massion PP; Hirsch FR; Minna JD; Gatsonis C; Duan F; Adams A; Apgar C; Medina RM; Aberle DR
    J Thorac Oncol; 2010 Oct; 5(10):1502-6. PubMed ID: 20871260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unlocking biomarker discovery: large scale application of aptamer proteomic technology for early detection of lung cancer.
    Ostroff RM; Bigbee WL; Franklin W; Gold L; Mehan M; Miller YE; Pass HI; Rom WN; Siegfried JM; Stewart A; Walker JJ; Weissfeld JL; Williams S; Zichi D; Brody EN
    PLoS One; 2010 Dec; 5(12):e15003. PubMed ID: 21170350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barrett's Esophagus and Esophageal Adenocarcinoma Biomarkers.
    Grady WM; Yu M; Markowitz SD; Chak A
    Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2486-2494. PubMed ID: 33093162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.